Stocks
KALA BIO, Inc.KALA
NASDAQHealthcareBiotechnology$0.19
Price as of · delayed, not real-time
A biopharmaceutical company focused on developing innovative therapies for eye diseases, with a lead product candidate targeting wet age-related macular degeneration. Its clinical-stage pipeline and proprietary drug delivery platform are key value drivers, though regulatory and commercialization risks remain. Investors track KALA BIO for its potential in the ophthalmology market and its progress through pivotal trials.
52W Range: $0.12-$95.50
Congressional Interest in KALA BIO, Inc. (KALA)
No congressional trades have been disclosed for KALA BIO, Inc. (KALA) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading KALA?
No congressional trades found for this stock.